Describe alterations in cholinergic neurotransmission and the use of acetylcholinesterase inhibitors
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
-
Brain and Behaviour 2 (Year 2)
- Lecture: Dementia
